The effects of intralesional human ADSCs on animal model of PD in acute phase was first assessed in 2013 ( Because of these potential limitations, a single-center, phase I, non-randomized study was conducted to evaluate the efficacy and safety of SC therapy for patients with PD using placental matrixderived mesenchymal SC (PM-MSCs) (Levy et al., 2015)
The process involves a weekly injection, with the exact dosing schedule tailored to the individuals response and tolerance to the medication
Figure 2 summarizes the multisystem actions of incretin-based therapy relevant to MASLD
Referral criteria for specialist evaluation need clarification and standardization
doi: 10.1089/jop.1999.15.143
Autonomic nerves, which control both voluntary and involuntary bodily functions such as blood pressure, may also be affected